Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
-
-
BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
-
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
-
Washington State sees 25-fold increase in whooping cough cases in 2024 compared to previous year
On Jun. 13, 2025, the Washington State Department of Health (DOH) reported that the state experienced a dramatic…
-
Japan draws up $700 Million Fund to attract foreign researchers
On Jun. 13, 2025, the Japanese government unveiled a 100 billion yen ($700 million) policy package designed to…
-
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
-
Tiny human hearts grown in pig embryos for the first time
On Jun. 13, 2025, researchers reported growing hearts containing human cells in pig embryos for the first time….
-
Pioneering cancer plasticity atlas will help predict response to cancer therapies
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
-
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59
On Jun. 12, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345),…
-
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
-
Twenty Measles Cases Confirmed in Montana
On Jun. 11, 2025, the Montana Department of Public Health and Human Services (DPHHS) reported a total of…
-
Iowa Health Officials Confirm Third Measles Case in the State
On Jun. 11, 2025, The Iowa Department of Health and Human Services (HHS) is reporting the state’s third…
-
Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses in Phase 3 Trial
On Jun. 11, 2025, Novavax announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent…
-
New therapeutic strategy help lower cholesterol levels by 50%
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
-
First-of-its-kind technology helps man with ALS ‘speak’ in real time
On Jun. 11, 2025, researchers at the University of California, Davis, announced they have developed an investigational brain-computer…
-
More Measles cases Reported in Central Texas
On Jun. 10, 2025, the Texas Department of State Health Services (DSHS) reported 744 cases of measles have…
-
Two patient cases of Legionella pneumonia reported
On Jun. 10, 2025, two patients treated within the past two months at the University of Washington Medical…
-
First-ever airborne toxin detected in Western Hemisphere
On Jun. 9, 2025, a team of University of Colorado, Boulder (CU Boulder) researchers who led a field…
-
Measles Exposure Site Confirmed in Oakland County, Michigan
On Jun. 9, 2025, Oakland County Health Division in Michigan is notifying the public about a measles exposure…
-
WHO says Mpox is an Ongoing health emergency
On Jun. 9, 2025, the World Health Organization (WHO) said the mpox outbreak is still a public health…
-
U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention RSV Lower Respiratory Tract Disease in Infants
On Jun. 9, 2025, Merck announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for…
-
Colorado health officials confirm two measles cases, release locations for potential exposures in Aurora and Colorado Springs
On Jun. 9, 2025, the Colorado Department of Public Health and Environment, the Arapahoe County Public Health Department,…
-
First Confirmed Cases of Measles in Arizona for 2025 Identified in Navajo County
On Jun. 9, 2025, the Navajo County Public Health Services District (NCPHSD), in coordination with the Arizona Department…
-
More new Measles cases Reported in Central Texas
On Jun. 6, 2025, the Texas Department of State Health Services (DSHS) reported 742 cases of measles have…
-
Kentucky Health Officials Confirm 2 Whooping Cough Deaths in Young Infants
On Jun. 6, 2025, officials with the Kentucky Department for Public Health (KDPH) announced that two infants have…
-
South Dakota Department of Health Reports Measles Exposure Possible at Rapid City Locations
On Jun. 6, 2025, the South Dakota Department of Health has notified the public of potential measles exposure…
-
Last Look: Critical Ebola Research from Now-Closed U.S. NIAID BSL-4 Lab
On Jun. 5, 2025, the final studies from the recently shuttered National Institute of Allergy and Infectious Diseases’…
-
USC Dornsife study reveals how protein droplets help cells master difficult DNA repair
On Jun. 5, 2025, research from University of Southern California, Dornsife (USC Dornsife) scientists reveals how cells fix…
-
LinusBio Launches Groundbreaking ClearStrand-ASD to aid Health Care Providers in Ruling Out Autism Using a Single Strand of Hair
On Jun. 5, 2025, LinusBio announced ClearStrand-ASD™, a first-of-its-kind diagnostic aid for autism spectrum disorder (ASD). ClearStrand-ASD is…
-
UBC Faculty of Medicine members receive 2023 Order of British Columbia
On Jun. 5, 2023, the University of British Columbia (UBC) announced that the faculty of medicine’s Drs. John…
